Found 12 results

Name Type of Offering Accepted Date
Celsus Therapeutics Plc. See All Filings
D 2013-09-30
Amount To Be Raised $12,516,232
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001541157-13-000002
Exclusions or Exemptions 506c
Accepted Date 2013-09-30
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets No Revenues
Type of Security Equity
Akari Therapeutics Plc See All Filings
D 2015-09-28
Amount To Be Raised $75,000,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001541157-15-000002
Exclusions or Exemptions 506b
Accepted Date 2015-09-28
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets Decline to Disclose
Type of Security Equity
Akari Therapeutics Plc See All Filings
D 2024-01-09 17:25:48
Amount To Be Raised $2,000,001
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0000911420-24-000004
Exclusions or Exemptions 506b
Accepted Date 2024-01-09 17:25:48
Type of Offering D
Industry Other Health Care
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Morria Biopharmaceuticals PLC See All Filings
D 2012-04-13
Amount To Be Raised $1,100,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001541157-12-000002
Exclusions or Exemptions N/A
Accepted Date 2012-04-13
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets No Revenues
Type of Security Equity
Morria Biopharmaceuticals PLC See All Filings
D 2013-02-01
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001144204-13-005403
Exclusions or Exemptions N/A
Accepted Date 2013-02-01
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets No Revenues
Type of Security Equity
Akari Therapeutics Plc See All Filings
D 2020-03-11 16:30:36
Amount To Be Raised $9,554,528
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001104659-20-031954
Exclusions or Exemptions 506b
Accepted Date 2020-03-11 16:30:36
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets Decline to Disclose
Type of Security Equity
Morria Biopharmaceuticals PLC See All Filings
D 2012-12-12
Amount To Be Raised $1,503,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001144204-12-067596
Exclusions or Exemptions N/A
Accepted Date 2012-12-12
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets No Revenues
Type of Security Equity
Akari Therapeutics Plc See All Filings
D 2019-07-12 16:32:19
Amount To Be Raised $4,499,945
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001144204-19-034585
Exclusions or Exemptions 506b
Accepted Date 2019-07-12 16:32:19
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
Akari Therapeutics Plc See All Filings
D 2023-10-19 16:17:36
Amount To Be Raised $1,971,001
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001567619-23-007516
Exclusions or Exemptions 506c
Accepted Date 2023-10-19 16:17:36
Type of Offering D
Industry Other Health Care
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Morria Biopharmaceuticals PLC See All Filings
D/A 2012-12-13
Amount To Be Raised $1,503,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001144204-12-067785
Exclusions or Exemptions N/A
Accepted Date 2012-12-13
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets No Revenues
Type of Security Equity
Akari Therapeutics Plc See All Filings
D 2022-09-27 16:16:30
Amount To Be Raised $12,835,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001104659-22-103309
Exclusions or Exemptions 506b
Accepted Date 2022-09-27 16:16:30
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business UNITED KINGDOM
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
Akari Therapeutics Plc See All Filings
D 2025-10-24 08:45:14
Amount To Be Raised $6,250,000
Associated Brokers / Dealers N/A
CIK Number 0001541157
Filed Document 0001493152-25-019187
Exclusions or Exemptions 506b
Accepted Date 2025-10-24 08:45:14
Type of Offering D
Industry Other Health Care
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire